Encephalitis II.pdf
-
Upload
chalid-ma-muthaher -
Category
Documents
-
view
240 -
download
0
Transcript of Encephalitis II.pdf
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 1/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com © 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 1 of 1
Encephalitis, InfectiousClinical Background
Encephalitis is an inflammatory process of the brain associated with varying degrees of brain dysfunction.
The presentation can be acute or chronic.
Epidemiology• Incidence – 1-2/100,000 in U.S.
• Age – most common in children <12 years
• Sex – M>F (minimal)
• Transmission – inhalational, vector borne (mosquito, tick), blood borne, gastrointestinal, or genital
• Etiology confirmed in ~30% of cases
Classification
• Infectious – viral (70%), bacter ial (20%), prion (6%), parasitic (3%), fungal (1%)
• Fungal, par asitic or tuberculosis agents more likely to cause chronic disease
• Host immune function is critical for establishing an infectious differential diagnosis
• Herpes simplex virus (HSV) is a common cause of viral encephalitis• 2,000 cases in the U.S. annually; up to 28% mortality
• Cytomegalovirus (CMV) and varicella-zoster virus (VZV) can cause a more aggressive form of
encephalitis in immunocompromised hosts
• Autoimmune (eg, systemic lupus erythematosus [SLE])
• Vasculitis
• Paraneoplastic infiltration
• Drug reactions
Organisms
• Viral – often initiated by nasopharyngeal colonization or acquisition on another skin or mucous membrane
surface
• HSV, human herpesvirus 6 and 7
• VZV
• Epstein-Barr virus (EBV)
• CMV
• Tick-bor ne viruses
• Mumps
• Measles
• Enterovirus
• Adenovirus
• Arboviruses (eg, West Nile virus)
• Lymphocytic choriomeningitis
• HIV
• Rabies
• Influenza virus
• Rubella virus
• Bacterial
• Chlamydia
• Mycoplasmas
• Legionella
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 2/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com
© 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 2 of 1
• Listeria
• Mycobacterium tuberculosis
• Nocardia
• Actinomyces
• Bartonella
• Brucella
• Borrelia
• Rickettsia rickettsii
• Rickettsia typhi
• Leptospira
• Tropheryma whippelii (Whipple disease)
• Treponema pallidum (meningovascular syphilis)
• Parasitic
• Toxoplasma
• Naegleria
• Acanthamoeba
• Balamuthia
• Echinococcus
• Plasmodium falciparum
• Trypanosoma spp
• Fungal
• Cryptococcus neoformans
• Histoplasma capsulatum
• Blastomyces dermatitidis
• Candida spp
Clinical Presentation
• Constitutional – fever, fatigue, myalgias• Neurologic – headache, altered consciousness, focal neurologic findings, seizures, coma
• Dermatologic – skin rashes (Lyme disease, typhus, rickettsial disease), skin lesions (VZV, HSV), bite-site
paresthesias (rabies)
• Gastroenterologic – nausea, emesis (enteroviral)
• Pulmonary – cough, dyspnea (mycobacteria)
Treatment
• Pathogen-specific; therapy limited to several viral agents
• Should be instituted as soon as possible if a presumptive diagnosis can be made
DiagnosisIndications for Testing
• Altered state of consciousness in appropriate clinical setting
Laboratory Testing
• CBC – not usually helpful, although leukocytosis may indicate a bacterial etiology and relative
lymphocytosis may suggest a viral etiology
• Peripheral smear
• Atypical lymphs – EBV
• Gametocytes – malaria
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 3/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com
© 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 3 of 1
• Morula – Ehrlichia, Anaplasma
• Spirochetes – relapsing fever, Borrelia
• Trypanosomes – trypanosomiasis
• Electrolyte panel, liver function studies – rule out metabolic encephalopathy
• Cerebrospinal fluid (CSF) studies – gram stain or other special stains if indicated (eg, India ink for
Cryptococcus, acid fast for TB), cell count with differential (usually have mononuclear pleocytosis),
protein (usually elevated), glucose (low in bacterial, fungal and mycobacterial infections)
• Head imaging (CT/MRI) should be performed in most patients prior to the lumbar puncture to rule out
significant cerebral edema
• Cultures – relatively poor sensitivity
• CSF fluid
• Blood – 2-3 sets from separate venipuncture sites prior to the administration of antibiotics
• Other site cultures may be helpful based on other organ system involvement (sputum, urine, body
fluid, tissue or gastric aspirate)
• Other tests to consider based on clinical history
• Antibody titers for viruses – comparison of CSF and serum antibody loads
• Ratio ≥20 indicates intrathecal production
• Intrathecal antibodies indicative of viral etiology
• PCR of fluids
• Greater sensitivity during first week of symptom onset while viral agent present in CSF; yield
decreases rapidly after the first week
• False negatives are most common during the first 2 days of symptoms
• In undiagnosed severe cases, PCR should be repeated after 3-7 days; serology should be
repeated in 4-6 weeks
• HSV by PCR – standard of care for diagnosis of HSV encephalitis
• Sedimentation rate/C-reactive protein for suspected vasculitis
Imaging Studies• MRI/CT to rule out structural lesions, demyelination and cerebral edema
• Temporal lobe enhancement suggestive of HSV-1
Other Tests
• EEG – may demonstrate seizure activity; most useful in HSV
Prognosis
• Determined mainly by pathogen and by patient immune status
Differential Diagnosis (non-infectious)
• Stroke
• Vasculitis• Autoimmune disease (most commonly SLE)
• Drug overdose
• Severe metabolic derangement (eg, metabolic acidosis, hyperglycemia)
• Malignancy – primary or metastatic
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 4/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com
© 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 4 of 1
Lab TestsIndications for Laboratory Testing
Tests generally appear in the order most useful for common clinical situations. For test-specific information, refer to the
test number in the ARUP Laboratory Test Directory on the ARUP Web site at www.aruplab.com.
Test Name and Number Recommended Use Limitations Follow Up
CBC with Platelet Count &
Automated Differential
0040003
Method:
Automated Cell Count with
Flow Cell Differential
Initial screening
Leukocytosis may indicate bacterial
etiology; relative lymphocytosis may
suggest viral etiology
Cell Count, CSF
0095018
Method:
Cell Count/Differential
Aid in differentiation of viral from
bacterial etiology
CSF Bacterial Culture
(Includes Gram Stain
0060101)
0060106
Method:
Standard reference
procedures for bacterial
stain, aerobic culture, and
identification
Aid in differentiation of viral from
bacterial etiology
70-80% sensitivity;
sensitivity decreases if
antibiotics given prior to
lumbar punch
Glucose, CSF
0020515
Method:Enzymatic
Aid in differentiation of viral from
bacterial etiology
Glucose loads are
normal in >95% of viral
cases
Protein, Total, CSF
0020514
Method:
Reflectance
Spectrophotometry
Evaluate meningeal fluid to rule out
meningitis
Electrolyte Panel
0020410
Method:
Quantitative Ion-Selective
Electrode/Enzymatic
Rule out metabolic encephalopathy
Hepatic Function Panel
0020416
Method:
Refer to individual
components.
Rule out metabolic encephalopathy
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 5/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com
© 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 5 of 1
Blood Culture
0060102
Method:
BACTEC® continuous
monitoring system.
Standard referenceprocedures for
identification of
aerobic and anaerobic
microorganisms
Identify cause of bacteremia Testing is limited to
the University of Utah
Health Sciences Center
only
Additional Tests Available
Test Name and Number Comments
Herpes Simplex Virus Culture
0065005
Method:
Cell Culture/Immunoassay
Poor sensitivity in CSF
Best to sample soon after symptom onset
Herpes Simplex Virus by PCR
0060041
Method:
Qualitative Polymerase Chain Reaction
96% sensitive; 99% specific when CSF is taken 2-7
days from symptom onset
Poor sensitivity during the first 24-48 hours after
symptom onset
Herpesvirus 6 (HHV6) (A&B), Quantitative PCR
0060071
Method:
Quantitative Polymerase Chain Reaction
Varicella-Zoster Virus DFA with Reflex to Varicella-Zoster
Virus Culture
0060282
Method:
Direct Fluorescent Antibody Stain
Varicella-Zoster Virus Antibody, IgG by ELISA (CSF)
0054444
Method:
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Superior to PCR VZV test
Epstein-Barr Virus Antibody Panel I
0050600
Method:
Semi-Quantitative Chemiluminescent Immunoassay
Epstein-Barr Virus Antibody Panel II0050602
Method:
Semi-Quantitative Chemiluminescent Immunoassay
Epstein-Barr Virus by PCR
0050246
Method:
Qualitative Polymerase Chain Reaction
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 6/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com
© 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 6 of 1
Cytomegalovirus Antibodies, IgG & IgM
0050622
Method:
Refer to individual components.
Cytomegalovirus by PCR
0060040
Method:
Qualitative Polymerase Chain Reaction
West Nile Virus Antibodies, IgG & IgM by ELISA, Serum
0050226
Method:
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Superior sensitivity compared to PCR testing
10% sensitivity at day 1; increases 10%/day,
peaking at 80% sensitivity by the end of first week of
symptoms
Borrelia burgdorferi Antibodies, Total by ELISA with Reflex to
IgG & IgM by Western Blot (Early Disease)
0050267
Method:
Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Qualitative Western Blot
Antibodies should be measured simultaneously in
serum and CSF
IgG and IgM useful if symptoms have been present
≤1 month
Borrelia Species DNA Detection by PCR (Lyme Disease)
0055570
Method:
Qualitative Polymerase Chain Reaction
Borrelia burgdorferi Antibodies, IgG & IgM by Western Blot
(CSF)
0055260
Method:
Qualitative Western Blot
For IgG, positive result reported when ≥5 bands are
present: 18, 23, 28, 30, 39, 41, 45, 58, 66, or 93kDA;
all other bandings reported as negative
For IgM, positive result reported when ≥2 bands are
present: 23, 39, or 41kDa; all others reported as
negativeRickettsia rickettsii (Rocky Mountain Spotted Fever)
Antibodies, IgG & IgM by IFA
0050371
Method:
Semi-Quantitative Indirect Fluorescent Antibody
Fourfold increase in titers from acute to
convalescent stage (2-4 weeks) is diagnostic
Francisella tularensis Antibodies, IgG and IgM
2005350
Method:
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Francisella tularensis Antibody, IgG
2005353Method:
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Francisella tularensis Antibody, IgM
2005354
Method:
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 7/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com
© 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 7 of 1
Ehrlichia chaffeensis Antibodies, IgG & IgM by IFA
0051002
Method:
Semi-Quantitative Indirect Fluorescent Antibody
Colorado Tick Fever Antibodies, IgG & IgM, IFA
0093167
Method:
Immunofluorescence Assay
Babesia microti Antibodies, IgG & IgM by IFA
0093048
Method:
Semi-Quantitative Indirect Fluorescent Antibody
Toxoplasma gondii by PCR
0055591
Method:
Qualitative Polymerase Chain Reaction
Echinococcus Antibody, IgG
0050250
Method:
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Mumps Virus Antibody, IgM
0099589
Method:
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Mumps Virus Antibody IgM, CSF
0054443
Method:Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Measles (Rubeola) Virus Culture
0065055
Method:
Cell Culture/Immunofluorescence
Measles (Rubeola) Antibodies, IgG & IgM
0050375
Method:
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Enterovirus Detection by RT-PCR
0050249
Method:
Qualitative Reverse Transcription Polymerase Chain Reaction
Identify one of the most common causes of viral
encephalitis
65-75% sensitive; 99% specific
Adenovirus Antibodies, IgG & IgM
0051077
Method:
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 8/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com
© 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 8 of 1
Arbovirus Antibodies, IgM, CSF
2001595
Method:
Semi-Quantitative Indirect Fluorescent
Antibody/Semi-Quantitative Enzyme-Linked Immunosorbent
Assay Arbovirus Antibodies, IgM, Serum
2001592
Method:
Semi-Quantitative Indirect Fluorescent
Antibody/Semi-Quantitative Enzyme-Linked Immunosorbent
Assay
Lymphocytic Choriomeningitis (LCM) Virus Antibodies, IgG &
IgM
2001635
Method:
Semi-Quantitative Indirect Fluorescent AntibodyLymphocytic Choriomeningitis (LCM) Virus Antibodies, IgG &
IgM, CSF
2001628
Method:
Semi-Quantitative Indirect Fluorescent Antibody
Human Immunodeficiency Virus Types 1 and 2 (HIV-1, HIV-2)
Antibodies with Reflex to Human Immunodeficiency Virus
Type 1 (HIV-1) Antibody Confirmation by Western Blot
2005377
Method:
Qualitative Chemiluminescent Immunoassay/Qualitative
Western Blot
Chlamydia pneumoniae by PCR
0060715
Method:
Qualitative Polymerase Chain Reaction
Mycoplasma pneumoniae by PCR
0060256
Method:
Qualitative Polymerase Chain Reaction
Legionella Species by PCR
0056105
Method:
Qualitative Polymerase Chain Reaction
Listeria Antibody, Serum by CF
0099529
Method:
Semi-Quantitative Complement Fixation
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 9/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com
© 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 9 of 1
AFB Culture (Includes AFB Stain 0060151)
0060152
Method:
Standard reference procedures for stain and culture.
Identification tests of AFB are ordered and billed separately.
DNA probes are available for M. tuberculosis complex and M.avium-intracellulare complex as indicated. DNA sequencing
and other molecular techniques are used for identification. For
drug susceptibilities, refer to Antimicrobial Susceptibility - AFB
Mycobacteria (ARUP test code 0060217).
Acid Fast Stain, Partial or Modified (for Nocardia sp.)
0060325
Method:
Stain/Microscopic Exam
Anaerobe Culture (Includes Gram Stain 0060101)
0060143
Method:Standard reference procedures for bacterial stain, anaerobic
culture and identification
Bartonella DNA Detection by PCR
0093057
Method:
Qualitative Polymerase Chain Reaction
Leptospira Culture
0060158
Method:
Standard reference procedures for Leptospira bacterial culture
and exam
Treponema pallidum (Rapid Plasma Reagin) with Reflex to
Titer
0050471
Method:
Semi-Quantitative Charcoal Agglutination
Acanthamoeba and Naegleria Culture
0060245
Method:
Qualitative Culture/Microscopic Identification
Trypanosoma cruzi Antibody, IgG
0051076
Method:
Semi-Quantitative Rapid Strip Assay
Cryptococcus Antigen, Serum
0050196
Method:
Semi-quantitative Enzyme Immunoassay
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 10/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com
© 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 10 of 1
Cryptococcus Antigen, CSF
0050195
Method:
Semi-quantitative Enzyme Immunoassay
Histoplasma Antigen by EIA, Serum
0092522
Method:
Semi-quantitative Enzyme Immunoassay
Blastomyces Antibodies by CF & ID
0050626
Method:
Semi-Quantitative Complement Fixation/Qualitative
Immunodiffusion
Fungal Culture
0060149
Method:
Standard reference procedures for fungal culture. Standardreference procedures for identification and/or ITS rDNA
Sequencing. DNA probes available for Histoplasma,
Coccidioides, and Blastomyces
Blood Culture, Fungal
0060070
Method:
BACTEC® Continuous Monitoring System.
Standard reference procedures for identification and/or DNA
Sequencing
Sedimentation Rate, Westergren (ESR)
0040325
Method:
Westergren
Determine symptoms involved in vasculitic-like
infections
C-Reactive Protein
0050180
Method:
Quantitative Immunoturbidimetric
Determine symptoms involved in vasculitic-like
infections
General References
Granerod J, Crowcr oft NS. The epidemiology of acute encephalitis.Neuropsychol Rehabil. 2007; 17 (4-5) :406-428.
Hunt WG. Meningitis and encephalitis in adolescents.Adolesc Med State Art Rev. 2010; 21 (2) :287-28x.
Lindquist L, Vapalahti O. Tick-borne encephalitis.Lancet. 2008; 371 (9627) :1861-1871.
Long SS. Encephalitis diagnosis and management in the real world.Adv Exp Med Biol. 2011; 697 :153-173.
Sejvar JJ. The evolving epidemiology of viral encephalitis.Curr Opin Neurol. 2006; 19 (4) :350-357.
Starza-Smith A, Talbot E, Grant C. Encephalitis in children: a clinical neuropsychology perspective.Neuropsychol
Rehabil. 2007; 17 (4-5) :506-527.
Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, Kennedy PG. Viral meningoencephalitis: a
review of diagnostic methods and guidelines for management.Eur J Neurol. 2010; 17 (8) :999-e57.
8/13/2019 Encephalitis II.pdf
http://slidepdf.com/reader/full/encephalitis-iipdf 11/12
The Physician's Guide to Laboratory Test Selection and Interpreta
ARUP LABORATORIES | 500 Chipeta Way | Salt Lake City, Utah 84108-1221 | (800) 522-2787 | www.arupconsult.com | www.aruplab.com
© 2006–2012 ARUP Laboratories. All Rights Reserved. Encephalitis, Infectious - p. 11 of 1
Stone MJ, Hawkins CP. A medical overview of encephalitis.Neuropsychol Rehabil. 2007; 17 (4-5) :429-449.
Reviewed by
Cook, Joshua B., MD. Digital Publications Assistant Editor at ARUP Laboratories; Anatomic and Clinical Pathology,
University of Utah
Fisher, Mark A., PhD. Medical Director, Bacteriology and Antimicrobials at ARUP Laboratories; Assistant Professor of
Pathology, University of Utah
Related Content
Acanthamoeba and Naegleria
Arboviruses
Bartonella Species
Bordetella pertussis - Whooping Cough
Borrelia burgdorferi - Lyme Disease
Brucella Species
Central Nervous System Tumors - Brain Tumors
Clostridium tetani - Tetanus
Cytomegalovirus - CMV
Dengue Fever Virus
Ehrlichiosis and Colorado Tick Fever
Enterovirus
Henoch Schönlein Purpura - IgA-Associated Vasculitis
Herpes Simplex Virus - HSV
Herpesvirus 6 - HHV6
Influenza Virus
Measles Virus - Rubeola
Meningitis, Acute
Mumps Virus
N-methyl-D-Aspartate (NMDA) type Glutamate Receptor Autoantibody Disorders - Anti-NMDA-Receptor Encephalitis
Paraneoplastic Neurological Syndromes
Rabies Virus
Rickettsia rickettsii - Rocky Mountain Spotted Fever
Rickettsia typhi - Typhus Fever
Rubella Virus
Schistosoma Species - Schistosomiasis
Sepsis in Newborns - Neonatal Sepsis
Staphylococcal Disease
Taenia Solium - Cysticercosis